Financing

Proceeds from warrant exercises

Year-over-year, this metric grew by 5600.0%, from $1.00K to $57.00K. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ1 2026May 6, 2026

How to read this metric

An increase indicates that warrant holders are converting their positions, providing cash to the company while increasing share count.

Detailed definition

This metric captures cash inflows resulting from the actual exercise of warrants by holders to purchase common stock. Un...

Peer comparison

Dependent on the company's warrant structure and market performance relative to exercise prices.

Metric ID: amd_proceeds_from_warrant_exercises

Historical Data

13 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.00K$0.00$3.00K$0.00$57.00K
QoQ Change-100.0%-100.0%
YoY Change>999%
Range$0.00$57.00K
Avg YoY Growth>999%
Median YoY Growth>999%

Frequently Asked Questions

What is Revolution Medicines, Inc.'s proceeds from warrant exercises?
Revolution Medicines, Inc. (RVMD) reported proceeds from warrant exercises of $57.00K in Q1 2026.
How has Revolution Medicines, Inc.'s proceeds from warrant exercises changed year-over-year?
Revolution Medicines, Inc.'s proceeds from warrant exercises increased by 5600.0% year-over-year, from $1.00K to $57.00K.
What does proceeds from warrant exercises mean?
Cash received when warrant holders exercise their right to buy company shares.